InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by SAHA SAURABH, Chairman & CEO. Insider active across 2 companies, notably Centessa Pharmaceuticals plc. Aggregated, 6 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €583k. Activity tracked since 16 November 2021. The latest transaction was filed on 13 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
8,178 shares@ US$2.440.0011% mcap100.0% of flowOrdinary SharesSEC:0001764046-26-000069
8,178 shares@ US$2.440.0011% mcap50.0% of flowOrdinary SharesSEC:0001764046-26-000069:0
5,000 shares@ US$9.740.0007% mcap7.4% of flowOrdinary SharesSEC:0000899243-22-004782:0
Ideal exit: 30 Oct 2022 (T+270)
5,000 shares@ US$9.740.0007% mcap14.8% of flowOrdinary SharesSEC:0000899243-22-004782
Ideal exit: 30 Oct 2022 (T+270)
23,000 shares@ US$12.28140.0041% mcap42.6% of flowOrdinary SharesSEC:0000899243-21-045311:0
Ideal exit: 13 Aug 2022 (T+270)
23,000 shares@ US$12.28140.0041% mcap85.2% of flowOrdinary SharesSEC:0000899243-21-045311
Ideal exit: 13 Aug 2022 (T+270)
6 of 6 declarations
About SAHA SAURABH
Saurabh Saha is the Chairman & CEO and Board Member of Centessa Pharmaceuticals plc and CLARIVATE PLC. In these roles, he oversees the operations and strategies of the companies, focusing on innovation and growth. His expertise in the pharmaceutical sector allows him to lead initiatives that enhance medical treatments and promote the development of new solutions.
